COLTENE (CLTN) H2 2025 earnings summary

Executive summary

• Net sales in 2025 were CHF 240 million, flat in local currencies but down 4.0% in Swiss francs due to FX headwinds, with no significant market share changes.

• Second half of 2025 saw a 4.7% growth in local currencies and an 11% operating margin, reflecting successful strategic execution.

• EBIT margin dropped to 8.8% from 10.7% year-over-year; net profit decreased 27% to CHF 14.9 million.

• Free cash flow fell to CHF 8.1 million, mainly due to lower net profit and increased working capital.

• Strategic investments in product innovation, digital marketing, and a new AI-capable CRM system supported operational improvements.

Financial highlights

• Net sales reached CHF 240 million, a 0.2% decrease in local currencies and a 4.0% decrease in Swiss francs.

• EBIT was CHF 21 million, with a margin of 8.8%, down 1.9 percentage points year-over-year.

• Net profit fell 27% to CHF 14.9 million, with a profit margin of 6.2%.

• Free cash flow was CHF 8.1 million, down 59.5% year-over-year.

• Equity ratio decreased to 54.9% from 58.2%.

Outlook and guidance

• Targeting low single-digit sales growth for 2026, aiming to outperform the market despite ongoing volatility.

• EBIT margin guidance for 2026 is 9%-10%, with a long-term target of 13–15% by 2028, delayed by one year.

• Profitability improvement expected from volume growth, operational efficiencies, price increases, and reduced tariff impact.

• Medium-term targets include annual sales growth of 3–5% in local currencies and a payout ratio of about 70%.